Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action) |
|||
OVERVIEW |
|||
SERIAL NUMBER | 88443368 | FILING DATE | 05/23/2019 |
REG NUMBER | 0000000 | REG DATE | N/A |
REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
INTL REG # | N/A | INTL REG DATE | N/A |
TM ATTORNEY | SPARACINO, MARK V |
L.O. ASSIGNED | 103 |
PUB INFORMATION |
|||
RUN DATE | 03/10/2021 | ||
PUB DATE | 07/14/2020 | ||
STATUS | 730-FIRST EXTENSION - GRANTED | ||
STATUS DATE | 03/08/2021 | ||
LITERAL MARK ELEMENT | GREENWORX | ||
DATE ABANDONED | N/A | DATE CANCELLED | N/A |
SECTION 2F | NO | SECTION 2F IN PART | NO |
SECTION 8 | NO | SECTION 8 IN PART | NO |
SECTION 15 | NO | REPUB 12C | N/A |
RENEWAL FILED | NO | RENEWAL DATE | N/A |
DATE AMEND REG | N/A |
FILING BASIS |
|||||
FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
44D | NO | 44D | NO | 44D | NO |
44E | NO | 44E | NO | 44E | NO |
66A | NO | 66A | NO | ||
NO BASIS | NO | NO BASIS | NO |
MARK DATA |
|
STANDARD CHARACTER MARK | YES |
LITERAL MARK ELEMENT | GREENWORX |
MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
PARTY TYPE | 20-OWNER AT PUBLICATION |
NAME | GreenLight Biosciences, Inc. |
ADDRESS | 200 Boston Avenue, Suite 1000 Medford, MA 02155 |
ENTITY | 03-CORPORATION |
CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
INTERNATIONAL CLASS | 001 |
DESCRIPTION TEXT | chemical reagents and RNA sequences being chemical reagents for agricultural purposes and not medical or veterinary purposes, namely, for crop protection and to improve plant health |
INTERNATIONAL CLASS | 005 |
DESCRIPTION TEXT | chemical reagents and RNA sequences being chemical reagents used to repel or destroy pests and vermin; Agricultural products, namely, herbicides, pesticides, fungicides; preparations for destroying vermin; Pharmaceutical products, aquaculture products, and veterinary products for human, aquaculture, and animal health in the nature of vaccines and RNA therapeutics for the treatment of infectious diseases, neurological diseases, metabolic diseases, cardiovascular diseases, respiratory diseases, immune system diseases, and cancer; Antibiotics; Vaccines; Gene therapy products, namely mRNA therapeutics and siRNA therapeutics for medical or clinical use for the treatment of infectious diseases, respiratory diseases, immune system diseases, cardiovascular diseases, and cancer; RNA in the nature of vaccines and therapeutics for scientific, research, medical, pharmaceutical, veterinary, agricultural, aquaculture, chemical and energy production, industrial and manufacturing use for the treatment of infectious diseases, neurological diseases, metabolic diseases, cardiovascular diseases, respiratory diseases, immune system diseases, and cancer |
INTERNATIONAL CLASS | 030 |
DESCRIPTION TEXT | Sugar and sugar substitutes |
GOODS AND SERVICES CLASSIFICATION |
|||||||
INTERNATIONAL CLASS | 001 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 030 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
CHANGE IN REGISTRATION | NO |
PSEUDO MARK | GREEN WORK |
PROSECUTION HISTORY |
||||
DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
03/10/2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 025 |
03/08/2021 | EX1G | S | EXTENSION 1 GRANTED | 024 |
03/08/2021 | EXT1 | S | EXTENSION 1 FILED | 023 |
03/08/2021 | EEXT | I | TEAS EXTENSION RECEIVED | 022 |
09/08/2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 021 |
07/14/2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 020 |
07/14/2020 | PUBO | A | PUBLISHED FOR OPPOSITION | 019 |
06/24/2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 018 |
06/10/2020 | ALIE | A | ASSIGNED TO LIE | 017 |
06/05/2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 016 |
06/03/2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 015 |
06/03/2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 014 |
06/03/2020 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | 013 |
12/11/2019 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | 012 |
12/11/2019 | GNFR | O | FINAL REFUSAL E-MAILED | 011 |
12/11/2019 | CNFR | R | FINAL REFUSAL WRITTEN | 010 |
11/25/2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 009 |
11/25/2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 008 |
11/25/2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 007 |
09/30/2019 | DOCK | D | ASSIGNED TO EXAMINER | 006 |
06/14/2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 005 |
06/14/2019 | GNRT | F | NON-FINAL ACTION E-MAILED | 004 |
06/14/2019 | CNRT | R | NON-FINAL ACTION WRITTEN | 003 |
06/07/2019 | DOCK | D | ASSIGNED TO EXAMINER | 002 |
06/07/2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
ATTORNEY | Christina M. Licursi |
CORRESPONDENCE ADDRESS | Christina M. Licursi WOLF, GREENFIELD & SACKS, P.C. 600 ATLANTIC AVENUE BOSTON MA 02210 |
DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
PARTY TYPE | 10-ORIGINAL APPLICANT |
NAME | GreenLight Biosciences, Inc. |
ADDRESS | 200 Boston Avenue, Suite 1000 Medford, MA 02155 |
ENTITY | 03-CORPORATION |
CITIZENSHIP | Delaware |